Analysis of human and primate CD2 molecules by protein sequence and epitope mapping with anti-human CD2 antibodies

Molecular Immunology

Volumn 41, Issue 10, 2004, Pages 985-1000

  Damschroder, Melissa M ^a   Kozhich, Alexander A ^a   Woods, Robert M ^a   Cheng, Li ^a   Mullikin, Brian A ^a   Wilson, Susan D ^a   Ulbrandt, Nancy D ^a   Bachy, Christine M ^a   Wu, Herren ^a   Suzich, JoAnn A ^a   Kiener, Peter A ^a   Dall'Acqua, William F ^a   White, Wendy I ^a  

^a MEDIMMUNE   (United States)

Author keywords

Antibodies; CD2; Epitopes; Mutagenesis; T lymphocytes

Indexed keywords

CD2 ANTIGEN; MONOCLONAL ANTIBODY;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BABOON; CHIMPANZEE; CONTROLLED STUDY; EPITOPE MAPPING; GENE MUTATION; HUMAN; HUMAN CELL; MOLECULAR CLONING; MONONUCLEAR CELL; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIBODIES; ANTIGENS, CD2; ANTIGENS, CD58; EPITOPE MAPPING; HAPLORHINI; HUMANS; PAN TROGLODYTES; SEQUENCE ANALYSIS, PROTEIN; T-LYMPHOCYTES;

CERCOPITHECUS AETHIOPS; PAN TROGLODYTES; PAPIO HAMADRYAS; PRIMATES; SUS SCROFA;

EID: 4043152039     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2004.05.004     Document Type: Article

References (39)

1. Arulanandam A.R., Withka J.M., Wyss D.F., Wagner G., Kister A., Pallai P., Recny M.A., Reinherz E.X. The CD5 8 (LFA-3) binding site is a localized and highly charged surface area on the AGFCC'C face of the human CD2 adhesion domain. Proc. Natl. Acad. Sci. U.S.A. 90:1993;11613-11617
2. Bierer, B.E., Bogart, R.E., Wolff, H.L., Burakoff, S.J., 1989. T2.2 Functional analysis of CD2 mAb reactivity. In: Knapp, W. (Ed.), Leukocyte Typing IV. Oxford University Press, New York.
3. Bierer B.E., Hahn W.C. T cell adhesion, avidity regulation and signalling: a molecular analysis of CD2. Semin. Immunol. 5:1993;249-261
4. Bodian D.L., Jones E.Y., Harlos K., Stuart D.I., Davis S.J. Crystal structure of the extracellular region of the human cell adhesion molecule CD2 at 2.5 A resolution. Structure. 2:1994;755-766
5. Branco L., Barren P., Mao S.Y., Pfarr D., Kaplan R., Langermann S., Koenig S., Johnson S. Selective deletion of antigen-specific, activated T cells by a humanized MAB to CD2 (MEDI-507) is mediated by NK cells. Transplantation. 68:1999;1588-1596
6. Clackson T., Wells J.A. A hot spot of binding energy in a hormone-receptor interface. Science. 267:1995;383-386
7. Dall'Acqua W., Goldman E.R., Eisenstein E., Mariuzza R.A. A mutational analysis of the binding of two different proteins to the same antibody. Biochemistry. 35:1996;9667-9676
8. Davis S.J., van der Merwe P.A. The structure and ligand interactions of CD2: implications for T cell function. Immunol. Today. 17:1996;177-187
9. Fox D.A., Hussey R.E., Fitzgerald K.A., Bensussan A., Daley J.F., Schlossman S.F., Reinherz E.X. Activation of human thymocytes via the 50KD T11 sheep erythrocyte binding protein induces the expression of interleukin 2 receptors on both T3+ and T3- populations. J. Immunol. 134:1985;330-335
10. Guex N., Peitsch M.C. Swiss model and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis. 18:1997;2714-2723
11. Harper M., Lema F., Boulot G., Poljak R.J. Antigen specificity and cross-reactivity of monoclonal anti-lysozyme antibodies. Mol. Immunol. 2:1987;97-108
12. Howard F.D., Ledbetter J.A., Wong J., Bieber C.P., Stinson E.B., Herzenberg L.A. A human T lymphocyte differentiation marker defined by monoclonal antibodies that block E-rosette formation. J. Immunol. 126:1981;2117-2122
13. Johnson S., Prince G.A., Hemming V.G., Pfarr D.S., Wang S.C., Dormitzer M., O'Grady J., Koenig S., Tamura J.K., Woods R., Bansal G., Couchenour D., Tsao E., Hall W.C., Young J.F. Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus. J. Infect. Dis. 176:1997;1215-1224
14. Johnsson B., Lofas S., Lindquist G. Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors. Anal. Biochem. 198:1991;268-277
15. Kim M., Sun Y., Byron O., Campbell G., Wagner G., Wang J., Reinherz E.L. Molecular dissection of the CD2-CD58 counter-receptor interface identifies CD2 Tyr86 and CD58 Lys34 residues as the functional "hot spot" J. Mol. Biol. 312:2001;711-720. Erratum in: 2001. J. Mol. Biol. 314, 331
16. Kozarsky K.F., Tsai C., Bott C.M., Allada G., Li L.L., Fox D.A. An antihCD2 monoclonal antibody that both inhibits and stimulates T cell activation recognizes a subregion of CD2 distinct from known ligand-binding sites. Cell. Immunol. 150:1993;235-246. Erratum in: 1995. Cell. Immunol. 163, 323
17. Kudo T., Suzuki M., Katayose Y., Shinoda M., Sakurai N., Kodama H., Ichiyama M., Takemura S., Yoshida H., Saeki H., Saijyo S., Takahashi J., Tominaga T., Matsuno S. Specific targeting immunotherapy of cancer with bispecific antibodies. Tohoku J. Exp. Med. 188:1999;275-288
18. Latinne D., De La Parra B., Nizet Y., Cornet A., Giovino-Barry V., Monroy R.L., White-Scharf M.E., Bazin H. An anti-CD2 mAb induces immunosuppression and hyporesponsiveness of CD2+ human T cells in vitro. Int. Immunol. 8:1996;1113-1119
19. Lipschultz C.A., Li Y., Smith-Gill S. Experimental design for analysis of complex kinetics using surface plasmon resonance. Methods. 20:2000;310-318
20. Makgoba M.W., Sanders M.E., Shaw S. The CD2-LFA-3 and LFA-1-ICAM pathways: relevance to T-cell recognition. Immunol. Today. 10:1989;417-422
21. Martin P.J., Longton G., Ledbetter J.A., Newman W., Braun M.P., Beatty P.G., Hansen J.A. Identification and functional characterization of two distinct epitopes on the human T cell surface protein Tp50. J. Immunol. 131:1983;180-185
22. Meuer S.C., Hussey R.E., Fabbi M., Fox D., Acuto O., Fitzgerald K.A., Hodgdon J.C., Protentis J.P., Schlossman S.F., Reinherz E.L. An alternative pathway of T-cell activation: a functional role for the 50 kd T11 sheep erythrocyte receptor protein. Cell. 36:1984;897-906
23. Miller G.T., Hochman P.S., Meier W., Tizard R., Bixler S.A., Rosa M.D., Wallner B.P. Specific interaction of lymphocyte function-associated antigen 3 with CD2 can inhibit T cell responses. J. Exp. Med. 178:1993;211-222
24. Moingeon P.H., Sayre P.H., Clayton L.K., Alcover A., Gardner P., Reinherz L. The structural biology of CD2. Immunol. Rev. 111:1989;111-144
25. Mrowietz U. Treatment targeted to cell surface epitopes. Clin. Exp. Dermatol. 27:2002;591-596
26. Nizet Y., Chentoufi A.A., de la Parra B., Lewalle P., Rouas R., Cornet A., Besse T., Mourad M., Malaise J., Squifflet J.P., Bazin H., Latinne D. The experimental (in vitro) and clinical (in vivo) immunosuppressive effects of a rat IgG2b anti-human CD2 mAb, LO-CD2a/BTI-322. Transplantation. 69:2000;1420-1428
27. Peterson A., Seed B. Monoclonal antibody and ligand binding sites of the T cell erythrocyte receptor (CD2). Nature. 329:1987;842-846
28. Pawelec G., Schaudt K., Rehbein A., Olive D., Buhring H.J. Human T cell clones with gamma/delta and alpha/beta receptors are differently stimulated by monoclonal antibodies to CD2. Cell. Immunol. 129:1990;385-393
29. Plunkett M.L., Springer T.A. Purification and characterization of the lymphocyte functkm-associated-2 (LFA-2) molecule. J. Immunol. 136:1986;4181-4187
30. Sanders M.E., Makgoba M.W., Sharrow S.O., Stephany D., Springer T.A., Young H.A., Shaw S. Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-gamma production. J. Immunol. 140:1988;1401-1407
31. Smith M.E., Thomas J.A. Cellular expression of lymphocyte function associated antigens and the intercellular adhesion molecule-1 in normal tissue. J. Clin. Pathol. 43:1990;893-900
32. Springer T.A., Dustin M.L., Kishimoto T.K., Marlin S.D. The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system. Annu. Rev. Immunol. 5:1987;223-252
33. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:1994;4673-4680
34. van der Merwe P.A., Barclay A.N., Mason D.W., Davies E.A., Morgan B.P., Tone M., Krishnam A.K.C., Ianelli C., Davis S.J. Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with a very low affinity and an extremely fast dissociation rate but does not bind CD48orCD59. Biochemistry. 33:1994;10149-10160
35. van Kemenade F.J., Tellegen E., Maurice M.M., Lankester A.C., Kuijpers T.W., Brouwer M., de Jong R., Miedema F., van Lier R.A. Simultaneous regulation of CD2 adhesion and signaling functions by a novel CD2 monoclonal antibody. J. Immunol. 152:1994;4425-4432
36. Wang J., Reinherz E.X. Structural basis of cell-cell interactions in the immune system. Curr. Opin. Struct. Biol. 10:2000;656-661
37. Wang J.H., Smolyar A., Tan K., Liu J.H., Kim M., Sun Z.Y., Wagner G., Reinherz E.L. Structure of a heterophilic adhesion complex between the human CD2 and CD58 (LFA-3) counter receptors. Cell. 97:1999;791-803
38. Wilder R.L. Integrm alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases. Ann. Rheum. Dis. 61:2002;ii96-ii99
39. Wolff H.L., Burakoff S.J., Bierer B.E. Functional CD2 mutants unable to bind to, or be stimulated by, LFA-3. J. Immunol. 144:1990;1215-1220